Home » Mental Health PGx Firm Assurex Health Nabs $30M Financing

Mental Health PGx Firm Assurex Health Nabs $30M Financing

Dec 23, 2014
|
staff reporter

NEW YORK (GenomeWeb) – Assurex Health today announced it has raised $30 million to support the clinical adoption and development of the firm's GeneSight neuropsychiatric pharmacogenomic products. 

Participants in the financing included new investors American Financial Group and Cross Creek Advisors, as well as existing investors Cincinnati Children's Hospital Medical Center, Sequoia Capital, Claremont Creek Ventures, Mayo Clinic, CincyTech, Allos Ventures, and Danmar Capital.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Drive Resistance

Gene drives might run into biological resistance, the Economist reports.

Dalí DNA Collected

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Synthetic-Conservation Biology Disconnect

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

This Week in Science

In Science this week: full CRISPR locus integration complex structure, and more.

What's Popular?

In Business News

  1. Danaher Q2 Revenues Grow 6 Percent; MDx Product Line Shut Down

  2. China's Direct Genomics Demonstrates Single-Molecule Sequencing of E. Coli

    Premium

  3. Courtagen Closes Genetic Testing Business, Citing Regulatory, Reimbursement Challenges

  4. Startup SpinDiag Raises €1.6M in Seed Funding

  5. Boreal Genomics Develops Method to Increase Accuracy, Reduce Cost of Liquid Biopsy

    Premium

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.